Filgrastim biosimilar (Virchow Group)

非格司亭生物类似药（Virchow Group）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Virchow Group)

Drug Alias Name非格司亭生物仿制药（Virchow Group）rhG-CSF (Virchow Group)重组人粒细胞刺激因子（Virchow Group）Recombinant human granulocyte macrophage colony stimulating factor (Virchow Group)Neutrogen

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesVirchow Group

China Registration ClassN/A

Develop Information

Active CompaniesVirchow Group

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA02